osteoporosis semaglutide GLP-1 Drugs May Raise the Risk of and Gout, Study Suggests Type 2 diabetes: Semaglutide may

Weight-Loss Guidance & Support A personalized plan tailored to your goals and adjusted as you progress

The SURMOUNT-3 trial had 806 obese adults without T2D undergo 12 weeks of intensive lifestyle intervention, before randomizing the 579 participants who lost 5% of their body weight to receive either tirzepatide or a placebo

So the goal is targeted support, not random mega dosing

For more information, ask to speak to the Pharmacist

Conservative treatment is the first-line approach, but if physiotherapy fails, there is no consensus in the literature on further therapy

This is a substantial achievement for many individuals